Novo Says Still Some Uncertainty on Tresiba Costs

Oct. 31 (Bloomberg) -- Novo Nordisk A/S Chief Financial Officer Jesper Brandgaard talks about the company's third-quarter profit reported today, sales forecast and the launch of its new diabetes treatment, Tresiba. He speaks from Bagsvaerd, Denmark, with Caroline Hyde on Bloomberg Television's "The Pulse." (Source: Bloomberg)

Sinopec 3Q Net Profit Rose to $1.5B
52:10 - It’s a big earnings week in China and among those reporting are some of the world's biggest oil companies. Bloomberg's Rosalind Chin reports on "Bloomberg Daybreak: Asia." (Source: Bloomberg)
  • Full Show: Bloomberg Technology (10/27)
  • Tan: BOJ's Stimulus Didn't Do Much for Economy
  • What Corporate Earnings Say About Health of U.S. Economy